| ²é¿´: 1196 | »Ø¸´: 4 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
mlijing_123½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
»Æ²¡¶¾ºÍ¿¹²¡¶¾Ò©ÎïµÄÑо¿ ÒÑÓÐ3È˲ÎÓë
|
||
|
Novartis Institute for Tropical Diseases (NITD) ¨C Singapore £º×ö»Æ²¡¶¾ºÍ¿¹²¡¶¾Ò©ÎïµÄÑо¿£¬¹«Ë¾Ê½ÔË×÷¡£ The Novartis Institute for Tropical Disease (NITD) is a Singapore-based tropical disease research institute created through a public-private partnership between Novartis and the Singapore Economic Development Board. Research at NITD focuses primarily on developing novel small molecule therapies for tropical infectious diseases that are endemic to the developing world, particularly dengue fever, malaria and tuberculosis |
» ²ÂÄãϲ»¶
±±¿Æ281ѧ˶²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
AÇøÏß²ÄÁÏѧµ÷¼Á
ÒѾÓÐ3È˻ظ´
319Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑоÀú
ÒѾÓÐ13È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
261ÇóBÇøµ÷¼Á£¬¿ÆÑоÀú·á¸»
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÀßÈí¹ÇÑ×ÒýÆðµÄÐØ±ÚÌÛÍ´ Ç󱿱ðÕâЩ´¦·½µÄ¿ÉÐŶȣ¡£¡£¡
ÒѾÓÐ20È˻ظ´
Öйú¸Î²¡¿¹²¡¶¾Ò©ÎïÊг¡Ñо¿±¨¸æ
ÒѾÓÐ29È˻ظ´
µÚÊ®½ìÈ«¹ú²¡¶¾Ñ§Ñ§ÊõÑÐÌÖ»á
ÒѾÓÐ6È˻ظ´
»ÆÎÄÁÖÖ÷±à¡ª¡ª·Ö×Ó²¡¶¾Ñ§ Ñо¿Éú½Ì²Ä
ÒѾÓÐ70È˻ظ´
º¼Ê¦´ó55Ïî
ÒѾÓÐ7È˻ظ´
¡¾·ÖÏí×ªÔØ¡¿°©Ö¢²¢²»¿ÉÅ£¬¿ÉŵÄÊÇ·ÅÆú£¡
ÒѾÓÐ3È˻ظ´
ÄäÃû
Óû§×¢Ïú (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 442.9
- É¢½ð: 44
- Ìû×Ó: 309
- ÔÚÏß: 94.4Сʱ
- ³æºÅ: 0
- ×¢²á: 2013-10-04
- רҵ: ¼¯³Éµç·Éè¼ÆÓë²âÊÔ
4Â¥2015-12-25 21:23:09
Ä©ÈÕ¿û»¨
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1742.8
- Ìû×Ó: 382
- ÔÚÏß: 447Сʱ
- ³æºÅ: 1212292
- ×¢²á: 2011-02-24
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
2Â¥2011-12-23 14:06:31
mlijing_123
½ð³æ (СÓÐÃûÆø)
- µãÆÀEPI: 4
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ¹ó±ö: 0.07
- ½ð±Ò: 185.7
- É¢½ð: 580
- ºì»¨: 4
- Ìû×Ó: 242
- ÔÚÏß: 116.6Сʱ
- ³æºÅ: 1170979
- ×¢²á: 2010-12-16
- ÐÔ±ð: GG
- רҵ: ²¡¶¾Ñ§
3Â¥2011-12-23 14:09:07
¹Ê¹úµÄº£°¶
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 1550.4
- ºì»¨: 3
- Ìû×Ó: 242
- ÔÚÏß: 72.4Сʱ
- ³æºÅ: 673553
- ×¢²á: 2008-12-12
- ÐÔ±ð: MM
- רҵ: ¿¹¸ÐȾҩÎïÒ©Àí
5Â¥2015-12-26 00:29:11













»Ø¸´´ËÂ¥